Associated Papers
NFE2 Truncation Mutants Protect Wild-Type NFE2 from ITCH-Dependent Degradation.
Hoeness ME et al.
International Journal of Molecular Sciences, 2025
41465537 (PubMed )
Supplement: ijms-26-12112-s001.zip › ijms-4008989-supplementary.pdf
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.
Jahn N et al.
Leukemia, 2022
35922444 (PubMed )
Supplement: 41375_2022_1650_MOESM2_ESM.xlsx › NGS_dataset
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations.
Simonetti G et al.
Leukemia, 2021
34193978 (PubMed )
Supplement: 41375_2021_1318_MOESM7_ESM.xlsx › S12-Variants
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.
Jutzi JS et al.
Blood, 2019
Select a paper to view details